Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial
Bosaeed et al., Infect. Dis. Ther., doi:10.1007/s40121-021-00496-6
https://c19hcq.org/bosaeed.html